Age-Related Molecular Degeneration Market is anticipated to expand at a CAGR of 7% by 2033

 The global Age-Related Molecular Degeneration Market is currently valued at US$ 11.28 Million in 2023 and is anticipated to expand at a CAGR of 7%. Owing to the technological advances in healthcare the market is likely to propel to US$ 22.19 Million by 2033.



“The expansion and development of the healthcare sector and rise in prevalence of age related molecular degeneration are likely to drive the growth of the age related molecular degeneration market in the forecast period.”

To learn more about this report @Age-Related Molecular Degenerationhttps://www.futuremarketinsights.com/reports/age-related-macular-degeneration-market

Most severe eye conditions are rising globally, and vision loss is becoming a significant public health issue and increase in the prevalence of the retinal disorder in many developed and developing nations drive market growth. The wet age-related macular degeneration segment is the highest contributor to the market and is expected to grow at a CAGR of 6.9% over the forecast period.

North America dominates the age-related molecular denegation market due to the presence of key market players' presence, along with recent product launches and established healthcare infrastructure, which will accelerate the market's growth in the region.

The significant R&D investments in Europe abode well for market growth. Growing awareness of macular degeneration in Asia-Pacific and the presence of key market players, and the rising elderly population in Japan all point to significant growth in the Japanese market for age-related molecular degeneration.

Key Takeaways from the Market Study

  • As of 2023, the age related molecular degeneration market was valued at US$ 11.28 Million
  • From 2023 to 2033, the age related molecular degeneration industry is poised to grow at an 7% CAGR
  • By 2033, the age related molecular degeneration market is slated to reach a valuation of US$ 22.19 Million
  • By distribution Channel, the hospital pharmacy segment accounted for the largest share of 55% and is expected to continue this trend over the forecast period.
  • China is poised to yield a CAGR of 6.8% with respect to age related molecular degeneration in 2033

“Growing healthcare spending and increase in the prevalence of AMD, retinal disorders are expected to radically transform the age-related molecular degeneration market in the coming years,” comments an analyst at FMI.

 Competitive Landscape

1.     Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Biogen, Samsung Bioepis, Ophthotech Corporation are some of the key players in the age related molecular degeneration industry.

The manufacturers are involved in the production of age related molecular degeneration in a larger capacity. Research and innovation are also conducted to launch innovative product for age related molecular degeneration.

  • In July 2021 - Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.
  • In June 2022– Biogen Inc. and Samsung Bioepis Co., Ltd announced that BYOOVIZ™ a biosimilar referencing LUCENTIS® has been launched in the United States. Healthcare provider engagement, promotional activity, collaborations with professional societies and patient advocacy groups have commenced and BYOOVIZ will be commercially available on July 1, 2022, through major distributors across the U.S.

Key Segments Covered in the Age-Related Molecular Degeneration Market Industry Survey

Age Related Molecular Degeneration Market by Product Type:

  • Eylea
  • Lucentis
  • Beovu
  • Others

Age Related Molecular Degeneration Market by Disease Type:

  • Dry AMD
  • Wet AMD

Age Related Molecular Degeneration Market by Distribution Channel:

  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy

 

Age-Related Molecular Degeneration
Age-Related Molecular Degeneration

Comments

Post a Comment

Popular posts from this blog

Orthopedic Trauma Devices Market is projected to reach a valuation of US$ 21.2 Bn by 2033 | FMI

Image
  The net worth of the Orthopaedic Trauma Devices Market is expected to increase from US$ 10.7 billion in 2023 to more than US$ 21.2 billion by 2033. From 2023 to 2033, the orthopaedic trauma device market is expected to grow at a 7.1% CAGR . To learn more about this report @ https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Orthopedic Trauma Devices market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Orthopedic Trauma Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcar
Read more

Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031

Image
Diabetes is becoming more common as poor lifestyle choices continue to be prominent around the world. Insulin pens are a widely used method of treating diabetic individuals. Given this, Future Market Insights predicts that insulin pen sales will reach US$ 30,407 million in 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster. Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential. Type 2 diabetes cases are common, but it can be prevented or de
Read more

Molecular Biology Enzymes, Kits & Reagents Market Size, Share, Growth, Forecast through 2032

Image
  According to a recent Future Market Insights report, the global Molecular Biology Enzymes, Kits & Reagents Market will grow dramatically between 2022 and 2032. By 2032, global sales of molecular biology enzymes, kits, and reagents are expected to total approximately US$ 48,476.41 million. Technological Advancements Leading to Enhanced Efficiency & Greater Precision of Molecular Biology Enzymes, Kits & Reagents The manufacturers of molecular biology enzymes, kits, and reagents have contributed significantly to technical breakthroughs by focusing on creating cutting-edge goods in an effort to diversify their product offerings. The cutting-edge items support the study procedures by providing features like increased precision and efficiency. One of the best instances of this is Thermo Fisher Scientific, Inc.’s SMART Digest Kit, which was created specifically for biopharmaceutical and proteomic applications. This kit reduces the time required for sample preparation while
Read more